Quantification of D-dimer levels in human saliva

Bioanalysis

Volumn 5, Issue 18, 2013, Pages 2249-2256

  Zhang, Xi ^a   Wan, Yunxia ^a   Cooper White, Justin ^a,b   Dimeski, Goce ^b,c   Atherton, John ^b   Punyadeera, Chamindie ^a,b  

^a Australian Institute for Bioengineering and Nanotechnology   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FLOW RATE; HUMAN; IMMUNOASSAY; LABORATORY DEVICE; LIMIT OF DETECTION; MALE; OUTCOME ASSESSMENT; PROCESS DEVELOPMENT; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; SALIVA LEVEL; CHEMISTRY; NORMAL HUMAN; PROCEDURES; SALIVA; YOUNG ADULT;

ADULT; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEALTHY VOLUNTEERS; HUMANS; IMMUNOASSAY; MALE; SALIVA; YOUNG ADULT;

EID: 84885009795     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.190     Document Type: Article

References (36)

1. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 379(9828), 1835-1846 (2012).
2. Cushman M, Folsom AR, Wang L et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 101(4), 1243-1248 (2003).
3. Wells PS, Anderson DR, Rodger M et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N. Engl. J. Med. 349(13), 1227-1235 (2003).
4. Rathbun SW, Whitsett TL, Vesely SK, Raskob GE. Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest 125(3), 851-855 (2004).
5. Ritchie DG, Levy BA, Adams MA, Fuller GM. Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. Proc. Natl Acad. Sci. USA 79(5), 1530-1534 (1982).
6. Mosesson MW. Fibrinogen and fibrin structure and functions. J. Thromb. Haem. 3(8), 1894-1904 (2005).
7. Brill-Edwards P, Lee A. D-dimer testing in the diagnosis of acute venous thromboembolism. Thromb. Haem. 82(2), 688-694 (1999).
8. Wells PS, Anderson DR, Rodger M et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N. Engl. J. Med. 349(13), 1227-1235 (2003).
9. Tripodi A. D-dimer testing in laboratory practice. Clin. Chem. 57(9), 1256-1262 (2011).
10. Froehling DA, Daniels PR, Swensen SJ et al. Evaluation of a quantitative D-dimer latex immunoassay for acute pulmonary embolism diagnosed by computed tomographic angiography. Mayo Clinic Proc. 82(5), 556-560 (2007).
11. Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood 113(13), 2878-2887 (2009).
12. Dirix LY, Salgado R, Weytjens R et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br. J. Cancer 86(3), 389-395 (2002).
13. Brotman DJ, Segal JB, Jani JT, Petty BG, Kickler TS. Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism. Am. J. Med. 114(4), 276-282 (2003).
14. Sivakumaran M, Malton N. Plasma D-dimer measurement as a predictor of venous thrombosis. Blood 102(13), 4618-4619 (2003).
15. Punyadeera C, Dimeski G, Kostner K, Beyerlein P, Cooper-White J. One-step homogeneous C-reactive protein assay for saliva. J. Immunol. Methods 373(1-2), 19-25 (2011).
16. Schulz BL, Cooper-White J, Punyadeera CK. Saliva proteome research: current status and future outlook. Crit. Rev. Biotechnol. (2012).
17. Mohammed R, Leigh Cambell J, Cooper-White J, Dimesky G, Punyadeera C: The impact of saliva collection and processing methods on Crp, Ige, and myoglobin immunoassays. Clin. Transl. Med. 1(1), 19 (2012).
18. Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C. Diagnostic potential of saliva: current state and future applications. Clin. Chem. 57(5), 675-687 (2011).
19. Topkas E, Keith P, Dimeski G, Cooper-White J, Punyadeera C. Evaluation of saliva collection devices for the analysis of proteins. Clinica Chimica Acta 413(13-14), 1066-1070 (2012).
20. Hu S, Li Y, Wang J et al. Human saliva proteome and transcriptome. J. Dent. Res. 85(12), 1129-1133 (2006).
21. Kiyosawa K, Sodeyama T, Tanaka E et al. Hepatitis C in hospital employees with needlestick injuries. Ann. Intern. Med. 115(5), 367-369 (1991).
22. Oksenhendler E, Harzic M, Le Roux JM, Rabian C, Clauvel JP. HIV infection with seroconversion after a superficial needlestick injury to the finger. N. Engl. J. Med. 315(9), 582-582 (1986).
23. Foo JY, Wan Y, Kostner K et al. NT-ProBNP levels in saliva and its clinical relevance to heart failure. PloS One 7(10), e48452 (2012).
24. Ovchinnikov DA, Cooper MA, Pandit P et al. Tumor-suppressor gene promoter hypermethylation in saliva of head and neck cancer patients. Transl. Oncol. 5(5), 321-326 (2012).
25. Nagadia R, Pandit P, Coman WB, Cooper-White J, Punyadeera C. miRNAs in head and neck cancer revisited. Cellular Oncology (Dordrecht) 36(1), 1-7 (2013).
26. Navazesh M, Kumar SKS. Measuring salivary flow: challenges and opportunities. J. Am. Dent. Assoc. 139(Suppl. 2), 35S-40S (2008)
27. Navazesh M. Methods for collecting saliva. Ann. NY Acad. Sci. 694, 72-77 (1993).
28. Poll EM, Kreitschmann-Andermahr I, Langejuergen Y et al. Saliva collection method affects predictability of serum cortisol. Clinica Chimica Acta international journal of clinical chemistry 382(1-2), 15-19 (2007).
29. PerkinElmer: Human D-dimer kit technical data sheet. AlphaLISA® Research Reagents TDS-AL290-01 (2011).
30. Jaedicke KM, Taylor JJ, Preshaw PM. Validation and quality control of ELISAs for the use with human saliva samples. J. Immunol. Methods 377(1-2), 62-65 (2012).
31. Hart A. Mann-Whitney test is not just a test of medians: differences in spread can be important. BMJ 323(7309), 391-393 (2001).
32. Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem 29(Suppl. 1), S49-S52 (2008).
33. Furie B, Furie BC. Mechanisms of thrombus formation. N. Engl. J. Med. 359(9), 938-949 (2008).
34. Berckmans RJ, Sturk A, Van Tienen LM, Schaap MC, Nieuwland R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood 117(11), 3172-3180 (2011).
35. Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM. Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia. Br. J. Haematol. 119(4), 1011-1016 (2002).
36. Rudnicka AR, Rumley A, Lowe GDO, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, c-reactive protein, tissue plasminogen activator, and von willebrand factor in a 45-year-old population. Circulation 115(8), 996-1003 (2007).